California State Teachers Retirement System (CalSTRS)’s SAB Biotherapeutics SABS Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio SABS Stock Details SABS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33K	Buy	+598	New	+$2.23K	﹤0.01%	2865

Other funds holding SABS

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s SABS Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) opened a new position in SAB Biotherapeutics (SABS) in Q2 2026: 598 shares worth $2.33K. The stake represents ﹤0.01% of the portfolio and ranks #2865 among its holdings.

87 funds tracked by Wall St. Rank hold SABS as of Q2 2026.

California State Teachers Retirement System (CalSTRS) held 598 shares of SAB Biotherapeutics worth $2.33K as of Q2 2026.
SAB Biotherapeutics was a new California State Teachers Retirement System (CalSTRS) position in Q2 2026.
SAB Biotherapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2865 holding.
87 funds tracked by Wall St. Rank held SAB Biotherapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.